335 related articles for article (PubMed ID: 26571193)
1. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
[TBL] [Abstract][Full Text] [Related]
2. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.
Pienaar IS; van de Berg W
Exp Neurol; 2013 Oct; 248():213-23. PubMed ID: 23769975
[TBL] [Abstract][Full Text] [Related]
3. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
[TBL] [Abstract][Full Text] [Related]
4. Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.
Elson JL; Kochaj R; Reynolds R; Pienaar IS
Neurotox Res; 2018 Jul; 34(1):16-31. PubMed ID: 29218504
[TBL] [Abstract][Full Text] [Related]
5. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
[TBL] [Abstract][Full Text] [Related]
6. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.
Elson JL; Yates A; Pienaar IS
Brain Struct Funct; 2016 May; 221(4):2319-41. PubMed ID: 25989851
[TBL] [Abstract][Full Text] [Related]
7. Nurr1, Pitx3, and α7 nAChRs mRNA Expression in Nigral Tissue of Rats with Pedunculopontine Neurotoxic Lesion.
Blanco-Lezcano L; Alberti-Amador E; González-Fraguela ME; Larrea GZ; Pérez-Serrano RM; Jiménez-Luna NA; Serrano-Sánchez T; Francis-Turner L; Camejo-Rodriguez D; Vega-Hurtado Y
Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31547185
[No Abstract] [Full Text] [Related]
8. Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?
Heise CE; Teo ZC; Wallace BA; Ashkan K; Benabid AL; Mitrofanis J
Anat Embryol (Berl); 2005 Nov; 210(4):287-302. PubMed ID: 16237536
[TBL] [Abstract][Full Text] [Related]
9. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.
Breit S; Lessmann L; Benazzouz A; Schulz JB
Eur J Neurosci; 2005 Nov; 22(9):2283-94. PubMed ID: 16262666
[TBL] [Abstract][Full Text] [Related]
10. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
11. Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats.
Chambers NE; Coyle M; Sergio J; Lanza K; Saito C; Topping B; Clark SD; Bishop C
Eur J Neurosci; 2021 Apr; 53(8):2835-2847. PubMed ID: 33426708
[TBL] [Abstract][Full Text] [Related]
12. Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model.
Breit S; Lessmann L; Unterbrink D; Popa RC; Gasser T; Schulz JB
Eur J Neurosci; 2006 Oct; 24(8):2275-82. PubMed ID: 17042796
[TBL] [Abstract][Full Text] [Related]
13. [The effects of lesions in the compact part of the substantia nigra on glutamate and GABA release in the pedunculopontine nucleus].
Blanco-Lezcano L; Rocha-Arrieta LL; Alvarez-González L; Martínez-Martí L; Pavón-Fuentes N; González-Fraguela ME; Bauzá-Calderín Y; Coro-Grave de Peralta Y
Rev Neurol; 2005 Jan 1-15; 40(1):23-9. PubMed ID: 15696422
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
Rolland AS; Tandé D; Herrero MT; Luquin MR; Vazquez-Claverie M; Karachi C; Hirsch EC; François C
J Neurochem; 2009 Aug; 110(4):1321-9. PubMed ID: 19527435
[TBL] [Abstract][Full Text] [Related]
15. Altered neuronal activity in the pedunculopontine nucleus: An electrophysiological study in a rat model of Parkinson's disease.
Geng X; Xie J; Wang X; Wang X; Zhang X; Hou Y; Lei C; Li M; Qu Q; He T; Han H; Yao X; Wang M
Behav Brain Res; 2016 May; 305():57-64. PubMed ID: 26924016
[TBL] [Abstract][Full Text] [Related]
16. Low-frequency stimulation of the pedunculopontine nucleus affects gait and the neurotransmitter level in the ventrolateral thalamic nucleus in 6-OHDA Parkinsonian rats.
Wen P; Li M; Xiao H; Ding R; Chen H; Chang J; Zhou M; Yang Y; Wang J; Zheng W; Zhang W
Neurosci Lett; 2015 Jul; 600():62-8. PubMed ID: 26054938
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
18. The neuronal activity of thalamic parafascicular nucleus is conversely regulated by nigrostriatal pathway and pedunculopontine nucleus in the rat.
Yan W; Zhang QJ; Liu J; Wang T; Wang S; Liu X; Chen L; Gui ZH
Brain Res; 2008 Nov; 1240():204-12. PubMed ID: 18823953
[TBL] [Abstract][Full Text] [Related]
19. [Effects of unilateral lesion of the nigrostriatal pathway by 6-OHDA on the neuronal activities of the pedunculopontine nucleus and the ventrolateral thalamic nucleus].
Liu H; Zhang J; Gao DM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 May; 25(2):212-6. PubMed ID: 21189555
[TBL] [Abstract][Full Text] [Related]
20. [Effects and mechanism of low frequency stimulation of pedunculopontine nucleus on spontaneous discharges of ventrolateral thalamic nucleus in rats].
Liu H; Lin YH; Cheng JH; Cai Y; Yu JW; Ma J; Gao DM
Sheng Li Xue Bao; 2011 Aug; 63(4):311-8. PubMed ID: 21861049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
